SUCLG1 and acute myeloid leukemia: CD34+ AML blasts derived from FLT3-ITD+ patients expressed significantly higher levels of SUCLG1 and 2, although also a subset of FLT3-wt patients expressed high levels of ETC complex II proteins (Fig. 1a).